AKT1 and cervical cancer: It is known that HPV18 oncoproteins can exert their oncogenic properties through targeting AKT [29], extracellular signal-regulated kinase (ERK) [30] and metalloprotease (MMP) [31, 32] pathways in cervical cancer cells, leading to cell survival, proliferation and metastasis.